Marksans Pharma Limited has informed the Exchange regarding a press release dated Jun 01, 2026, titled "Marksans Pharma to Acquire 100% of Netherlands-based QliniQ B.V., Strengthening Presence in European Markets".
Press Release Jun 01 2026
Filed with NSE · · 5 pages · English
Summary by 6ix AI
Marksans Pharma Limited has announced its acquisition of QliniQ B.V., a Netherlands-based pharmaceutical company, to enhance its presence in European markets. The acquisition will provide Marksans with established sales and marketing capabilities in the Netherlands, supporting its growth strategy in regulated European markets. This strategic move is expected to bolster Marksans' market access and commercialization efforts for its product portfolio in Europe.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Marksans Pharma Limited on 6ix
Earlier from Marksans Pharma
- Press Release May 26 2026
- Press Release Apr 01 2026
- Press Release Feb 05 2026
- Press Release Nov 20 2025
- Press Release Nov 19 2025
Later from Marksans Pharma
- Marksans Pharma Limited Press Release Jul 08 2026
- Marksans Pharma Limited Press Release Aug 12 2026
- Marksans Pharma Limited has informed the Exchange regarding a press release dated November 04, 2026, titled "Press release dated 4 November 2026 regarding unaudited financial results for the quarter and half year ended 30 September 2026.".
Follow Marksans Pharma into a list and get an email when it puts out news.
Follow Marksans Pharma